National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 75440-75441 [E8-29280]

Download as PDF 75440 Federal Register / Vol. 73, No. 239 / Thursday, December 11, 2008 / Notices manufacturer’s assistance, information on video conferencing and electronic submissions, Mammography Matters, and other device-oriented information. The CDRH Web site may be accessed at http://www.fda.gov/cdrh. A search capability for all CDRH guidance documents is available at http:// www.fda.gov/cdrh/guidance.html. Guidance documents are also available on the CBER Internet site at http:// www.fda.gov/cber/guidelines.htm or on the Division of Dockets Management Internet site at http:// www.regulations.gov. IV. Paperwork Reduction Act of 1995 This guidance refers to previously approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA) (44 U.S.C. 3501–3520). The information collection provisions in 21 CFR part 814, subpart B (Premarket Approval Applications (PMAs)) in this guidance have been approved under OMB control number 0910–0231. This approval expires November 30, 2010. V. Comments mstockstill on PROD1PC66 with NOTICES Interested persons may submit to the Division of Dockets Management (see ADDRESSES) written or electronic comments regarding this document. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at http://www.regulations.gov. Dated: December 5, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8–29330 Filed 12–11–08; 8:45 am] BILLING CODE 4160–01–S VerDate Aug<31>2005 17:27 Dec 10, 2008 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel CTSA 1. Date: February 10–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington DC/Rockville Hotel, Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Mohan Viswanathan, PhD, Deputy Director, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Blvd., Dem. 1, Room 1084, MSC 4874, Bethesda, MD 20892–4874, 301–435–0829, mv10f@nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; CTSA–2. Date: February 18–19, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington DC /Rockville Hotel, Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Mohan Viswanathan, PhD, Deputy Director, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Blvd., Dem. 1, Room 1084, MSC 4874, Bethesda, MD 20892–4874, 301–435–0829, mv10f@nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel RCMI–COBRE. Date: February 25–26, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Wash. DC/Rockville Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Steven Birken, PhD, Scientific Revew Officer, Office of Review, National Center for Research Resources, 1 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 Democracy Plaza, Room 1078, 6701 Democracy Blvd., Bethesda, MD 20892, 301– 435–0815, birkens@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; RCMI Infrastructures for Clinical and Translational Research (RCTR). Date: March 4, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Carol Lambert, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, National Institute of Health, 6701 Democracy Boulevard, 1 Democracy Plaza, Room 1076, Bethesda, MD 20892–4874, (301) 435–0814, lambert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS) Dated: December 4, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–29272 Filed 12–10–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Research Scientist Development Awards. Date: December 18, 2008. Time: 8:30 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: The Westin Arlington Gateway, 801 N. Glebe Road, Arlington, VA 22203. Contact Person: Mark Roltsch, PhD, Scientific Review Administrator, Review Branch/DERA, National Heart, Lung, and E:\FR\FM\11DEN1.SGM 11DEN1 Federal Register / Vol. 73, No. 239 / Thursday, December 11, 2008 / Notices Blood Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892–7924, 301–435– 0287, roltschm@nhlbi.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Short-Term Research Education Projects. Date: December 18–19, 2008. Time: 3:30 p.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: The Westin Arlington Gateway, 801 N. Glebe Road, Arlington, VA 22203. Contact Person: Mark Roltsch, PhD, Scientific Review Administrator, Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892–7924, 301–435– 0287, roltschm@nhlbi.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Institutional National Research Service Awards. Date: December 22, 2008. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, RK II, 6701 Rockledge Drive, Rm. 7176, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Roy L White, PhD, Scientific Review Administrator, Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7176, Bethesda, MD 20892–7924, 301–435– 0310, whiterl@nhlbi.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: December 4, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–29280 Filed 12–10–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES mstockstill on PROD1PC66 with NOTICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice VerDate Aug<31>2005 17:27 Dec 10, 2008 Jkt 217001 is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Autoimmune Centers of Excellence Review. Date: January 5–7, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Quirijn Vos, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301–451–2666, qvos@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 4, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–29278 Filed 12–10–08; 8:45 am] DATES: 75441 Effective Date: January 12, 2009. FOR FURTHER INFORMATION CONTACT: Hugo Teufel III, Chief Privacy Officer, Department of Homeland Security, Washington, DC 20528, by telephone (703) 235–0780 or facsimile 1–866–466– 5370. SUPPLEMENTARY INFORMATION: Pursuant to the provisions of the Privacy Act of 1974, 5 U.S.C. 552a, and as part of its ongoing integration and management efforts, the Department of Homeland Security (DHS) is consolidating one U.S. Citizenship and Immigrations Services (USCIS) system of records notice titled, Justice/INS–024 FD–258 Fingerprint Tracking System (65 FR 46741 July 31, 2000) into the existing U.S. Citizenship and Immigration Services system of records notice titled DHS–USCIS–002 U.S. Citizenship and Immigration Services Background Check Service, (72 FR 31082 January 5, 2007). Justice/INS–024 FD–258 Fingerprint Tracking System was originally established to determine the status of pending fingerprint submissions to the Federal Bureau of Investigation (FBI) and the results of the FBI check, and to account for and control the receipt and processing of fingerprints submitted to the FBI for a criminal background check. Eliminating this system of records notice will have no adverse impact on individuals, but will promote the overall streamlining and management of DHS Privacy Act record systems. BILLING CODE 4140–01–P Dated: December 2, 2008. Hugo Teufel III, Chief Privacy Officer, Department of Homeland Security. [FR Doc. E8–29260 Filed 12–10–08; 8:45 am] DEPARTMENT OF HOMELAND SECURITY BILLING CODE 4410–10–P Office of the Secretary Privacy Act of 1974; Consolidation of U.S. Citizenship and Immigration Services Background Check Service System of Records Privacy Office, DHS. ACTION: Notice to consolidate one Privacy Act system of records notice. AGENCY: SUMMARY: In accordance with the Privacy Act of 1974, the Department of Homeland Security is giving notice that it proposes to consolidate one Privacy Act system of records notice, Justice/ INS–024 FD–258 Fingerprint Tracking System, July 31, 2000, into the existing U.S. Citizenship and Immigration Services system of records notice titled DHS–USCIS–002 U.S. Citizenship and Immigration Services Background Check Service, January 5, 2007. PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 DEPARTMENT OF HOMELAND SECURITY Office of the Secretary Privacy Act of 1974; System of Records Privacy Office, DHS. Notice of removal of one Privacy Act system of records notice. AGENCY: ACTION: SUMMARY: In accordance with the Privacy Act of 1974, the Department of Homeland Security is giving notice that it will remove one system of records notice from its inventory of record systems because the United States Coast Guard no longer requires the system. The obsolete system is DOT/CG 632 Uniformed Services Identification and Privilege Card Record System (April 11, 2000). E:\FR\FM\11DEN1.SGM 11DEN1

Agencies

[Federal Register Volume 73, Number 239 (Thursday, December 11, 2008)]
[Notices]
[Pages 75440-75441]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29280]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Research Scientist Development Awards.
    Date: December 18, 2008.
    Time: 8:30 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Arlington Gateway, 801 N. Glebe Road, 
Arlington, VA 22203.
    Contact Person: Mark Roltsch, PhD, Scientific Review 
Administrator, Review Branch/DERA, National Heart, Lung, and

[[Page 75441]]

Blood Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD 
20892-7924, 301-435-0287, roltschm@nhlbi.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Short-Term Research Education Projects.
    Date: December 18-19, 2008.
    Time: 3:30 p.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Arlington Gateway, 801 N. Glebe Road, 
Arlington, VA 22203.
    Contact Person: Mark Roltsch, PhD, Scientific Review 
Administrator, Review Branch/DERA, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892-7924, 
301-435-0287, roltschm@nhlbi.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Institutional National Research Service 
Awards.
    Date: December 22, 2008.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, RK II, 6701 Rockledge 
Drive, Rm. 7176, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Roy L White, PhD, Scientific Review 
Administrator, Review Branch/DERA, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7176, Bethesda, MD 20892-7924, 
301-435-0310, whiterl@nhlbi.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: December 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-29280 Filed 12-10-08; 8:45 am]
BILLING CODE 4140-01-P